India – Piramal Pharma has appointed OMD India, part of Omnicom Media Group, to manage its integrated media mandate following a competitive multi-round pitch. OMD India will drive brand growth through sharp, creative, and forward-leaning communication strategies.
In this appointment, OMD India will oversee strategic marketing and media efforts for Piramal Pharma’s OTC brands, including Lacto Calamine, Little’s, Tetmosol, Polycrol, and women’s intimate health products such as i-pill and i-activ. The account will be managed from OMD India’s Mumbai office.
OMD will also develop and implement a media strategy aimed at expanding Piramal Pharma’s market presence, increasing brand visibility, driving consumer engagement, and supporting business growth.
Anisha Iyer, CEO of OMD India, shared, “We are excited to embark on this partnership with Piramal Consumer Healthcare, a company that mirrors our commitment to innovation and excellence.”
“This collaboration presents a significant opportunity to leverage our strategic acumen and deep market intelligence to elevate Piramal’s impressive portfolio of brands to new heights. Together, we aim to craft media strategies that go beyond visibility—building lasting trust and loyalty with consumers across India and shaping a future of sustained growth and impact,” Iyer continued.
